Cell Transplantation for Neurological Disorders

1 The Lund Transplant Program for Parkinson’s Disease and Patients with MPTP-Induced Parkinsonism.- 2 Fetal Nigral Transplantation in Parkinson’s Disease: The USF Pilot Program (12- to 24-Month Evaluation).- 3 Toward a Phase III Multicenter Study of Fetal Ventral Mesencephalic Transplants in Patients with Late-Stage Parkinson’s Disease.- 4 PET Studies of Transplantation Therapy.- 5 Neuropathology of Dopaminergic Transplants in Patients with Parkinson’s Disease.- 6 Fetal-Tissue Transplantation for Huntington’s Disease: Preclinical Studies.- 7 Fetal Transplantation for Huntington’s Disease: Clinical Studies.- 8 Topographic Factors Affecting the Functional Viability of Dopamine-Rich Grafts in the Neostriatum.- 9 Immunological Issues in Rodent and Primate Transplants (Allografts).- 10 Transplanting Fetal Neural Xenogeneic Cells in Parkinson’s and Huntington’s Disease Models.- 11 Animal Models of Cerebral Ischemia: Neurodegeneration and Cell Transplantation.- 12 Transplantation Strategies for the Treatment of Pain.- 13 Treatment of Central Nervous System Diseases with Polymer-Encapsulated Xenogeneic Cells.- 14 Transplant Strategies in Myelin Disorders.- 15 Somatic Gene Transfer and Cell Transplantation Strategies for Neurodegenerative Diseases.- 16 Adequately Respecting and Protecting Fetal Tissue Donors and Their Next-of-Kin.